Crescent Capital BDC- 5% NT REDEEM 25/05/2026 USD 25 EBIT

Crescent Capital BDC- 5% NT REDEEM 25/05/2026 USD 25 posts a EBIT of $63M as of March 2025. That compares with $270M in the prior-year period — down 76.7% year over year. That is below the Finance sector average of $330B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Crescent Capital BDC- 5% NT REDEEM 25/05/2026 USD 25's EBIT was $270M. The latest reading is $63M — a 76.7% year-over-year decrease (period ending March 2025). Use the history and growth charts on this page for a longer lookback.

For Finance stocks, a EBIT near $330B is typical. Crescent Capital BDC- 5% NT REDEEM 25/05/2026 USD 25's $63M is lower that level. That is roughly 100.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Crescent Capital BDC- 5% NT REDEEM 25/05/2026 USD 25's financial statement story. At $63M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for FCRX's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $330B), and (3) consistency with growth and profitability. This page covers the first two; Crescent Capital BDC- 5% NT REDEEM 25/05/2026 USD 25's other metric pages and overview cover the third.